Riskpilot← Back to searchSign inGet full accessKaramela AB
ABActiveOrg 5592582778S:T Olofsgatan 10 BMedical specialists activities · NACE 8622Est. 20200 employees
Revenue 2024
SEK 291K
-24% vs 2023
EBITDA margin
83.6%
-23% vs 2023
Equity ratio
87.6%
Financial strength
Net profit 2024
SEK 608K
+67% vs 2023
| Revenue | SEK 291K | -24% |
| EBITDA | SEK 244K | -23% |
| Net profit | SEK 608K | +67% |
| Total assets | SEK 1,2M | -11% |
| Equity | SEK 1M | +151% |
| Employees | 0 | — |
Legal name
Karamela AB
Org number
5592582778
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
3 juni 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva medicinska konsultationer samt utbildnings och expertuppdrag inom epidemiologi, obstetrik, gynekologi och psykiatri. Bolaget ska äga och förvalta lös egendom samt därmed förenlig verksamhet.
Address
S:T Olofsgatan 10 B
Email
info@karamela.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 236 | 114 | 107 | 385 | 291 |
| Staff expenses | — | — | −3 | −4 | −0 |
| EBITDA | 218 | 51 | 66 | 318 | 244 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 218 | 51 | 66 | 318 | 244 |
| Net financials | — | — | −1 | 110 | 410 |
| Profit before tax | 219 | 52 | 66 | 428 | 653 |
| Tax | −47 | −11 | −14 | −63 | −45 |
| Net profit | 172 | 41 | 52 | 365 | 608 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 298 | 161 | 154 | 1 303 | 1 155 |
| Equity | 197 | 87 | 139 | 404 | 1 012 |
| Long-term debt | 0 | 0 | — | 861 | 117 |
| Short-term debt | 102 | 74 | 14 | 38 | 26 |
| Total debt | 102 | 74 | 14 | 899 | 143 |
EBITDA margin
83.6%
This company
15.8%
Market median
+429% vs market
20202024
Equity ratio
87.6%
This company
38.2%
Market median
+129% vs market
20202024
Return on equity
60.1%
This company
18.4%
Market median
+227% vs market
20202024
Net profit margin
208.8%
This company
8.1%
Market median
+2478% vs market
20202024
Asset turnover
0.25×
This company
1.12×
Market median
-78% vs market
20202024
Debt / equity
0.14×
This company
0.62×
Market median
+77% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-06-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Karamela AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Fotios Papadopoulos | Board of Directors | 0 companies |
| Alkistis Skalkidou | Deputy Board Member | 0 companies |